Xenon Pharmaceuticals Inc (XENE)

Sales/Maturities of Investments

$708.46M

TTM · Period ending: · USD

XENE logo

XENE Sales/Maturities of Investments

Latest reported$708.46M
XENE Sales/Maturities of Investments ($14.18M → $708.46M)
High-resolution chart · PNG

XENE sales/maturities of investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xenon Pharmaceuticals Inc Sales/Maturities of Investments — Annual fiscal periods (USD)
Period endingSales/Maturities of Investments (USD)
574,454,000
700,343,000
682,354,000
258,028,000
144,754,000
214,710,000
75,443,000
48,522,000
52,616,000
0
10,745,000
13,539,000
6,550,000
1,010,000
14,179,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.